Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 13, 2017 - Issue 3
Submit an article Journal homepage
691
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder

Massimiliano BuoliDepartment of Psychiatry, University of Milan, Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, Milan, ItalyCorrespondence[email protected]
View further author information
,
Alice CaldiroliDepartment of Psychiatry, University of Milan, Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, Milan, ItalyView further author information
&
Marta SeratiDepartment of Psychiatry, University of Milan, Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, Milan, ItalyView further author information
Pages 351-359 | Received 05 Oct 2016, Accepted 09 Jan 2017, Published online: 20 Jan 2017

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Alice Caldiroli, Enrico Capuzzi, Ilaria Tagliabue, Luisa Ledda, Massimo Clerici & Massimiliano Buoli. (2023) New frontiers in the pharmacological treatment of social anxiety disorder in adults: an up-to-date comprehensive overview. Expert Opinion on Pharmacotherapy 24:2, pages 207-219.
Read now
Pascal Kintz, Alice Ameline & Jean-Sébastien Raul. (2018) Assessment of Pregabalin Use by Hair Testing. Substance Use & Misuse 53:12, pages 2093-2098.
Read now
Massimiliano Buoli, Silvia Grassi, Marta Serati & A. Carlo Altamura. (2017) Agomelatine for the treatment of generalized anxiety disorder. Expert Opinion on Pharmacotherapy 18:13, pages 1373-1379.
Read now

Articles from other publishers (10)

Alice Caldiroli, Lia Colzani, Enrico Capuzzi, Cecilia Quitadamo, Davide La Tegola, Teresa Surace, Stefania Russo, Mauro Capetti, Silvia Leo, Agnese Tringali, Matteo Marcatili, Francesco Zanelli Quarantini, Fabrizia Colmegna, Antonios Dakanalis, Massimiliano Buoli & Massimo Clerici. (2023) Clinical Markers of Panic and Generalized Anxiety Disorder: Overlapping Symptoms, Different Course and Outcome. Journal of Personalized Medicine 13:3, pages 491.
Crossref
Alvaro Henrique Bernardo de Lima Silva, Debora Rasec Radulski, Gabriela Saidel Pereira, Alexandra Acco & Janaina Menezes Zanoveli. (2022) A single injection of pregabalin induces short- and long-term beneficial effects on fear memory and anxiety-like behavior in rats with experimental type-1 diabetes mellitus. Metabolic Brain Disease 37:4, pages 1095-1110.
Crossref
Rafaela Figueiredo Rodrigues, Juliana Barbosa Nunes, Sandra Barbosa Neder Agostini, Paloma Freitas dos Santos, Juliana Cancino-Bernardi, Rodrigo Vicentino Placido, Thamyris Reis Moraes, Jennifer Tavares Jacon Freitas, Gislaine Ribeiro Pereira, Flávia Chiva Carvalho, Giovane Galdino & Vanessa Bergamin Boralli. (2021) Preclinical Evaluation of Polymeric Nanocomposite Containing Pregabalin for Sustained Release as Potential Therapy for Neuropathic Pain. Polymers 13:21, pages 3837.
Crossref
Vimal M. Aga, Mujeeb U. Shad, Hongru Zhu & Carl Salzman. 2020. Handbook of Mental Health and Aging. Handbook of Mental Health and Aging 315 399 .
Jeremy DeMartiniGayatri PatelTonya L. Fancher. (2019) Generalized Anxiety Disorder. Annals of Internal Medicine 170:7, pages ITC49.
Crossref
Sharon L. Crowell‐Davis, Thomas F. Murray & Leticia Mattos DantasSharon L. Crowell‐Davis, Mami Irimajiri & Leticia Mattos Dantas. 2019. Veterinary Psychopharmacology. Veterinary Psychopharmacology 147 156 .
Stephen Merrigan & Kamisha L. Johnson-Davis. 2019. LC-MS in Drug Analysis. LC-MS in Drug Analysis 119 127 .
Elena Vashchinkina, Ossi Piippo, Olga Vekovischeva, Evgeny Krupitsky, Ruslan Ilyuk, Nikholay Neznanov, Kirill Kazankov, Igor Zaplatkin & Esa R. Korpi. (2017) Addiction‐related interactions of pregabalin with morphine in mice and humans: reinforcing and inhibiting effects. Addiction Biology 23:3, pages 945-958.
Crossref
Bourin Michel. (2018) Clinical pharmacology of anxiolytics. Archives of Depression and Anxiety, pages 021-025.
Crossref
Marina Dyskant Mochcovitch, Rafael Christophe da Rocha Freire, Rafael Ferreira Garcia & Antonio Egidio Nardi. (2017) Can Long-Term Pharmacotherapy Prevent Relapses in Generalized Anxiety Disorder? A Systematic Review. Clinical Drug Investigation 37:8, pages 737-743.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.